Fastsense Diagnostics is focused on developing low-cost high efficiency diagnostics devices for complex diseases such as cancer. Their current focus is to develop a hand-held portable electrochemical diagnostic/screening system for liver cancer. Cancer is a complex disease and there is no portable system is available for primary screening or monitoring. The proposed device will be critical in primary screening and monitoring of liver cancer in remote areas or resource-poor regions where even basic heath care facilities are not available. FastSense Diagnostics was founded by Dr. Preeti Joshi. The team has basic expertise in nanotechnology, electrochemistry, biomedical devices and electronics.
Kozhnosys is a start-up involved in the development of biomedical devices with the aim of building cost-effective and easy to use medical diagnostic devices using cutting-edge technology. Currently they are developing a routine screening device for cancer. The company is working towards demonstrating proof of concept for a novel molecular-imprinted polymer coated quartz crystal microbalance sensor for rapid breath based routine screening for breast cancer, by identifying elevated concentration of volatile markers in exhaled breath.
In-Med Prognostics brings affordable, accessible, reliable, and data-driven brain health prognostics and diagnostics tools to India and other emerging markets. Their proprietary software, Neuroshield™ integrates MRI images, clinical reports and psychological assessments to produce automated, quantified reports to support the physician’s clinical impression for various neurological disorders and provides a seamless, end-to-end cloud based image analysis platform for clinical and research use. Leveraging state-of-the-art data analytics and deep learning methodologies, they are developing a biomarker algorithm for various neurological disorders starting with paediatric epilepsy and dementia.
Currently, they offer segmentation services and comparative volumetric analysis reports to clinical end-users and research support for clinical imaging based projects for pharma and life sciences customers. Their aim is to build an Indian databank for neurological disorders consisting of complete clinical data including radiology. In-Med was founded by Rajesh Purushottam, Dr. Latha Poonamallee & Dr. Al Curran.
(a) Rotary Endodontic file in basket form to be used in root canal treatment of teeth.
(b) GumCair: An innovative medical device that will use air/ gas to heal or to prevent the progression or recurrence of gum disease (periodontitis) after primary clinical cure
(c) Healer: A software that may be combined with hardware to help keep track of disease and prescriptions. The primary aim is to be able to register the incidence of disease pattern and the pattern of drug use geographically. The software can be particularly useful to government agencies in regulating the indiscriminate use of antibiotics and obtaining live data for monitoring the prevalence of disease in a particular area.
(d) Dental Services: DZeal also plans to providing evidence-based dental treatment at affordable rates. They are currently working from one location in Mumbai, and hope to expand their network in the near future.
Vitiligo is a skin condition in which white patches appear on the skin due to the death of color-producing cells. This debilitating disease is a cause of immense psychological torment and is considered as a social stigma. At Ahammune, their endeavour is to resolve and treat the long-standing skin depigmentation disorder Vitiligo that has
affected the life of millions of people. They are currently developing new chemical/molecular entities (NCE/NME’s) for stalling the spread of depigmentation in Vitiligo.
Early wound assessment and management is very crucial with the rise in Skin and Soft Tissue Infections (SSTI), ranging from diabetic foot ulcers, surgical site infections, burns, dermatology skin infections etc. Although it was estimated that an ankle is lost to diabetes somewhere in the world every 30 seconds, a more important fact is that up to 85% of all amputations in diabetes should be preventable. Conventional methods of SSTI monitoring are very ineffective. The problem is further compounded in low resource settings due to lack of quality infrastructure. Adiuvo Diagnostics is developing a non-invasive, portable Skin-Scope device to detect, classify major clinically relevant bacteria and fungus causing the infections in real time, and also access the rate of healing within 2 minutes. This will aid the doctors with early and right treatment protocol.
BioPrime AgriSolutions Pvt Ltd is using its pioneering, innovative research & products in the areas of agriculture, horticulture & floriculture. Specifically, they are working on developing technologically advanced, affordable, better products for soil, crop & water management to the farmers, regardless of their farmland size.
The company has been awarded the prestigious Biotechnology Ignition Grant (BIG) from BIRAAC, DBT for developing new solutions in plant breeding. BioPrime’spatented“organo-nano-regulator technology” uses agriculture biologicals to activate/regulate/modulate certain novel targets in plant or pest physiology. Their products combine the precision and rapid action obtained by synthetic/chemical inputs with the goodness of organic products. Their products are aligned with their vision of 100% organic, zero pesticide and zero residue farming.
They are working towards developing a ready-to-use biosurfactant-based formulation, that can successfully aid all household consumers to decontaminate and sanitize their fruits and vegetables before consumption. This unique 100% organic formulation removes 99% of pesticides, chemicals, toxins, pathogens, germs and other lethal substances. Washing of fruits and vegetables in this formulation has been shown to curtail the shrinking of produce and double the shelf life of products even without refrigeration, which can have a huge market in the rural sector, where the over 70 million households have poor access or no access to electricity. The unique selling point of their formulation is that it is odorless, tasteless, non oily, non-sticky, retains natural taste and does not require a rewash step in plain water, which not only helps save water but also simplifies the cleaning process for large-scale cleaning operations at distribution and export centers. This product finds application with farmers for exporting their produce free of any chemicals and pesticides and avoid rejection, at hotels, community centers, consumers etc.
WeInnovate Biosolutions Pvt. Ltd is startup whose mission is to develop affordable and rapid healthcare-therapeutic solutions. Currently, they are developing a formulation for accelerated healing of critical wounds. “HealRap” is their novel product for healing of diabetic foot ulcers. They are also involved in development of diagnostic solutions for antimicrobial susceptibility testing within 1 hour. Their mentors include medical doctors, business strategists, pre-clinical and clinical studies advisors, product building experts.
Annweshan is a spin-off based on NCL ‘s technology created under Venture Center’s “Lab2Mkt” program. The company wishes to develop innovative health care & biotech products at affordable costs and commercialize these products. Currently Annweshan is working to develop a metabolite (non-nucleic acid) biomarker based novel TB diagnostic kit for sensitive (can detect MTB missed by smear microscopy), specific (to MTB in sputum samples), fast, easy, instrument- free, cheap and point-of-care detection of M. tuberculosis bacilli in patient’s sputum as well as severity of disease in patients. The company has received Biotechnology Ignition Grant by DBT-BIRAC, GoI
NEX is a provider of integrated environmental solutions with a mission to minimize environmental impact of human activity through managing waste from collection to disposal, while recovering valuable resources and creating clean and renewable energy. NEX specializes in processing of “Organic Food Waste” with cutting edge Anaerobic Digestion (AD) technology to generate bio gas rich in methane and CO2, which will be compressed and commercialized to replace fossil fuel. NEX LLP is the subsidiary company of NEX to manage the contract of of processing 500 tons of organic waster per day in Pune.
Abhiruchi is a spin-off based on NCL ‘s technology created under Venture Center’s “Lab2Mkt” program . The company is working towards demonstrating the proof of concept for a novel formulation (patent protected) comprising a strain of Brevibacterium casei AP9 for a probiotic food additive, which will help reduce cholesterol absorption in the GI tract with potential long lasting action (as seen by higher and faster in-vitro Bile Salt Hydrolase(BSH) production than other LABs and as seen by higher adhesion to mucin layer). Abhiruchi has received Biotechnology Ignition Grant by DBT-BIRAC, GoI
Biolmed is a spin-off based on NCL ‘s technology created under Venture Center’s “Lab2Mkt” program. The start-up aim to develop biomedical products for healthcare applications for human bone defects like bony voids, long bone defects and traumatic /surgical osseous defects. The company’s first product will be a osteoconductive bone graft substitute kit based on the silk-fibroin material. Biolmed has received Biotechnology Ignition Grant by DBT-BIRAC, GoI
VIVIRA is a spin-off based on NCL’s technology. The Start–up plans to develop a novel and patent protected vortex diode based cavitation device (VodCa®) for enhancing bio-gas yield and throughput of anaerobic digesters. In-particular, prove the concept for biological digesters used in distillery industries (enhance throughput per m3 of digester and gas yield per m3 of spent wash by 20%). The technology has applications in several agri- and marine- biotech industries.
Module is a spin-off based on NCL ‘s technology created under Venture Center’s “Lab2Mkt” program. The start-up is developing affordable and innovative diagnostic devices for rapid microbial detection. The company will leverage the platform technology developed at CSIR-NCL Pune to develope quick, colorimetric, portable and reusable biosensor based on nanofibers for E.coli O157:H7 sensing and detection. The team has already demonstrated reversible thermal chromism and solvent chromism in nanofibers of PCDA/PHBV by doping ZnO nanoparticles and Color change by Biotin-Streptavidin interaction in solution phase. The company has received Biotechnology Ignition Grant by DBT-BIRAC, GoI. They have also been featured at various news media including Economic Times, Times of India and Pixr 8. Module is founded by two engineers Sachin Dubey and usman Khan both of them holding B.Tech and M.tech from University of Rajasthan, Jaipur.
NEX is a provider of integrated environmental solutions with a mission to minimize environmental impact of human activity through managing waste from collection to disposal, while recovering valuable resources and creating clean and renewable energy. NEX specializes in processing of “Organic Food Waste” with cutting edge Anaerobic Digestion (AD) technology to generate bio gas rich in methane and CO2, which will be compressed and commercialized to replace fossil fuel. They have developed a proprietary one-box biogas technology.
Winnergy Bangalore project: Bangalore Municipal corporation (BBMP) has appointed NEX to design, build and operate a 250TPD of food waste- compressed bio gas processing plant. Nex has signed a tri-partite agreement with Bruhat Bangalore Hotels Association (BBHA) & BBMP to process 250 tons of organic waster per day. Noble Exchange is founded by Nuriel Pezarkar, MBA and Ex-Kimberly Clark India, Shweta Negi- MBA, Ex-Kimberly Clark India and Sumedh Bapat a Mechanical engineer and MBA.
Periwnkle Technologies is a platform based company for comprehensive healthcare management through mobile and web based app. Their proprietary app called “Bhramar Health” is an unique healthcare platform. Periwinkle is founded and run by Koustubh Naik and Veena Moktali. both of the founders hold BE and MS in Engineering Management from San Jose State University. The company is a recipient of SPARSH grant by DBT-BIRAC, GoI
Founded in 2010, Shantani Proteome Analytics Pvt. Ltd. is a privately-held biotechnology company that provides novel chemical-proteomics based technologies and services to identify & validate drug targets; thus de-risking molecules and supporting crucial GO / NO-GO decisions throughout the drug discovery process. The company has received SPARSH and SBIRI grant by DBT-BIRAC , GoI. The company has also raised early stage seed capital and angel funding. Shantani is founded by Dr. Chaitanya Saxena who is a seasoned professional and bring successful experience of developing technologies for drug-target deconvolution and drug-target interaction measurements in intact biological systems from his tenure at Eli Lilly & Company. Chaitanya earned a Ph.D. from The Ohio State University, Columbus, OH, USA.
Nayam innovations is a biomaterial based company working towards developing novel Intra-Ocular Lens (IOL) to provide spectacle-free vision to patients undergoing cataract surgery. The company has received Biotechnology Ignition Grant by DBT-BIRAC, GoI, and raised seed funding through grant and equity investments. Nayam Innovations is founded by Tanuj Gigras who holds a B.Tech and M.Tech in Engineering Physics from IIT Bombay.